The Positive Expression of PD-L1/PD-1 in Gastroenteropancreatic Neuroendocrine Neoplasias Correlates with Prognosis

被引：0
|
作者：
Yinying, W. [1 ]
Chuying, W. [1 ]
机构：
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China
来源：
NEUROENDOCRINOLOGY | 2017年 / 105卷
关键词：
gastroenteropancreatic neuroendocrine neoplasias; pd-l1; pd-1; immunohistochemistry; prognosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
G19
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [1] The Clinical Significance of PD-L1/PD-1 Expression in Gastroenteropancreatic Neuroendocrine Neoplasia
    Wang, Chuying
    Yu, Jiao
    Fan, Yangwei
    Ma, Ke
    Ning, Jing
    Hu, Yuan
    Niu, Wenxia
    Dong, Xuyuan
    Wu, Yinying
    Li, Enxiao
    Dong, Danfeng
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2019, 49 (04): : 448 - 456
  • [2] PD-1 and PD-L1 expression in neuroendocrine carcinomas of bladder
    Erdogan, S.
    Acikalin, A.
    Bagir, E. Kilic
    Inceman, M.
    VIRCHOWS ARCHIV, 2020, 477 : S159 - S159
  • [3] PD-1 AND PD-L1 EXPRESSION ON THE PROGNOSIS OF OVARIAN CANCER
    Li, R. P.
    Li, W. Y.
    Guo, Y. Z.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (04): : 1161 - 1166
  • [4] Analysis of PD-1/PD-L1 blockade biomarker and immune infiltrates in gastroenteropancreatic neuroendocrine carcinoma
    Xing, J. Z.
    Bai, C.
    Cheng, Y.
    Sun, Z.
    Gao, Y.
    Li, J.
    ANNALS OF ONCOLOGY, 2019, 30 : 568 - 568
  • [5] PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma
    Ma, Ke
    Wei, Xin
    Dong, Danfeng
    Wu, Yinying
    Geng, Qianqian
    Li, Enxiao
    ONCOLOGY LETTERS, 2017, 14 (01) : 250 - 256
  • [6] Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors
    Sampedro-Nunez, Miguel
    Serrano-Somavilla, Ana
    Adrados, Magdalena
    Cameselle-Teijeiro, Jose M.
    Blanco-Carrera, Concepcion
    Manuel Cabezas-Agricola, Jose
    Martinez-Hernandez, Rebeca
    Martin-Perez, Elena
    Munoz de Nova, Jose Luis
    Angel Diaz, Jose
    Garcia-Centeno, Rogelio
    Caneiro-Gomez, Javier
    Abdulkader, Ihab
    Gonzalez-Amaro, Roberto
    Marazuela, Monica
    SCIENTIFIC REPORTS, 2018, 8
  • [7] Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors
    Miguel Sampedro-Núñez
    Ana Serrano-Somavilla
    Magdalena Adrados
    José M. Cameselle-Teijeiro
    Concepción Blanco-Carrera
    José Manuel Cabezas-Agricola
    Rebeca Martínez-Hernández
    Elena Martín-Pérez
    José Luis Muñoz de Nova
    José Ángel Díaz
    Rogelio García-Centeno
    Javier Caneiro-Gómez
    Ihab Abdulkader
    Roberto González-Amaro
    Mónica Marazuela
    Scientific Reports, 8
  • [8] PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
    Ali, Abir Salwa
    Langer, Seppo W.
    Federspiel, Birgitte
    Hjortland, Geir Olav
    Gronbaek, Henning
    Ladekarl, Morten
    Welin, Staffan
    Vestermark, Lene Weber
    Arola, Johanna
    Osterlund, Pia
    Knigge, Ulrich
    Sorbye, Halfdan
    Micke, Patrick
    Grimelius, Lars
    Gronberg, Malin
    Janson, Eva Tiensuu
    PLOS ONE, 2020, 15 (12):
  • [9] Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: a potential target for anti PD-1/PD-L1 therapy
    Roberts, Jordan A.
    Gonzalez, Raul S.
    Das, Satya
    Berlin, Jordan
    Shi, Chanjuan
    HUMAN PATHOLOGY, 2017, 70 : 49 - 54
  • [10] Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors
    Fan, Yangwei
    Ma, Ke
    Wang, Chuying
    Ning, Jing
    Hu, Yuan
    Dong, Danfeng
    Dong, Xuyuan
    Geng, Qianqian
    Li, Enxiao
    Wu, Yinying
    ONCOTARGETS AND THERAPY, 2016, 9 : 6075 - 6082
12345